The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...

At this year’s Veeva R&D and Quality Summit, it was revealed that Novo Nordisk and Veeva have entered into a new partnership ...

Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...

For the first time ever, the Inaugural Multi-Omics Based Drug Discovery & Development Summit 2025 has been positioned as the ...

The 7th Exosome-Based Therapeutics Development Summit with never-before-seen data, covering the end-to-end from discovery ...

Cosmo Feilding Mellen – currently Beckley's chief executive, who is slated to serve as chief strategy officer of the merged ...

The analysis by the Royal College of Paediatrics and Child Health suggests the main barriers to access are factors like ...

A new task force comprising staff from the UK medicines regulator, the MHRA, and cost-effectiveness arbiter NICE – with the ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

Galapagos announces leadership transition. European biotechnology company Galapagos completed a significant leadership ...

Amgen acquired Five Prime in 2021 on the back of the phase 2 FIGHT trial of bemarituzumab, which achieved significant ...

Hikma's announcement ties into that sentiment, coming with the strap line: "America Leans on Hikma: Quality Medicines ...